As theories continue to emerge for the dramatic turnaround in overdose deaths, a new study indicates that it's largely unrelated…
On December 18 the Government Accountability Office (GAO) released a report on fentanyl and methamphetamine sales by Mexican transnational drug-trafficking…
On December 3, the Drug Enforcement Administration launched Fentanyl Free America, “a comprehensive enforcement initiative and public awareness campaign aimed…
The Food and Drug Administration is reportedly providing guidance and “positive feedback” for a proposed nalmefene product that will last…
“He was awesome,” Alexis Pleus, executive director of Truth Pharm, a small harm reduction organization based in Binghamton, New York,…
The Drug Enforcement Administration has raised aggregate production quotas (APQ) for the active ingredients in Adderall, Ritalin and Concerta, as…
In late September, Representatives Adam Gray (D-CA) and Gabe Evans (R-CO) introduced the “Combatting Fentanyl Poisonings Act of 2025.” It's…
Indivior PLC has discontinued marketing for Opvee, the opioid-overdose reversal product that the pharmaceutical company had claimed was more effective…
Lenacapavir, the new long-acting HIV prevention medication that hit the United States market with a price tag of over $28,000…
The era of direct-to-consumer (DTC) pharmaceutical commercials may be coming to a close. On September 9, President Donald Trump signed…